Neurotech Pharmaceuticals, Inc. Granted Fast Track

Neurotech Pharmaceuticals, Inc. Granted Fast Track Designation from the U.S. FDA for the Treatment of Macular Telangiectasia type 2.


View PDF Version




MacTel_FastTrack
.pdf
Download PDF • 106KB


40 views